Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Gynecology · Uterine Polyps

Do Obesity, Diabetes, or Hypertension Cause Uterine Polyps?

At a Glance

Uterine polyps have no single proven cause. Hormonal responses, tamoxifen or certain hormone therapies, and possibly obesity or diabetes may be associated with their development, but these conditions do not directly prove why a polyp formed; hypertension has a weaker link.

It is natural to wonder why a uterine polyp developed, but there is no single proven cause, and doctors usually cannot pinpoint an exact reason for any individual person [1][2]. Current research suggests that polyps form due to a combination of localized tissue growth, genetic changes acquired specifically within the cells of the polyp (which does not mean you have an inherited cancer risk), and how the lining of the uterus responds to hormones [3][4]. While conditions like obesity, diabetes, and hypertension (high blood pressure) are often listed as risk factors, they are not proven to directly cause polyps [5]. Most importantly, developing a uterine polyp is not your fault.

Important Safety Note: Any vaginal bleeding or spotting after menopause, even if it is light or only happens once, should be evaluated by a healthcare provider promptly.

The Role of Hormones

Uterine polyps are overgrowths of the endometrium (the inner lining of the uterus). This tissue naturally responds to the hormones estrogen and progesterone. Evidence suggests that polyps might develop when the tissue has an altered response to estrogen, or when there is estrogenic stimulation without adequate progesterone balancing it out [6][1].

Known hormonal exposures, such as the breast cancer medication tamoxifen or certain hormone therapies, are associated with a higher likelihood of developing polyps [7][8]. However, these are considered contributing factors rather than a universal cause, and many people develop polyps without any known hormonal imbalance [6]. Never stop or alter your tamoxifen or prescribed hormone treatments without consulting your prescribing doctor. The crucial medical benefits of these treatments often far outweigh the potential risk of a polyp.

Understanding Obesity, Diabetes, and Hypertension

When reading about uterine polyps, you may see obesity, diabetes, and high blood pressure listed as “risk factors.” It is crucial to understand the difference between an association and a cause.

Research shows that metabolic conditions and higher body weight are associated with the presence of polyps in some groups [5][9]. Observational studies (research that observes groups of people rather than testing a direct cause) have found that individuals with a higher body mass index (BMI) or diabetes are more likely to have a polyp [5][10]. Because obesity, diabetes, and hypertension often cluster together in the same individuals, it is difficult to determine the independent contribution of each condition [5]. Furthermore, other studies have found no such differences between groups [11].

The evidence linking hypertension to the development of polyps is even weaker [5][12]. Having these metabolic changes might create a biological environment that encourages polyp growth, but having diabetes or high blood pressure does not mean you caused your polyp [13][14].

Age, Menopause, and What This Means for You

Age and menopausal status influence the behavior of polyps and how doctors manage them. Uterine polyps are commonly detected in the perimenopausal years (leading up to menopause) and after menopause [15][16]. Research indicates that in younger, premenopausal individuals, polyps are more likely to regress (go away) on their own, whereas they tend to be more persistent after menopause [17][18].

While the vast majority of polyps are benign (noncancerous), the risk of atypical (precancerous) or cancerous cells within a polyp is higher in older or postmenopausal patients, especially those who experience postmenopausal bleeding [19][20].

Because of this, treatment is highly individualized. Doctors do not remove every polyp; the decision depends on your symptoms, menopausal status, the polyp’s features on ultrasound, and your personal medical history. Some asymptomatic, low-risk polyps can be safely monitored. In other cases, the doctor will recommend removal so the tissue can be sent to a pathology lab. In the lab, the tissue is examined under a microscope to definitively determine whether it is a benign polyp, hyperplasia with atypia, or cancer [20].

Focusing on Overall Health

Because the exact cause of a uterine polyp is usually unknown, there is no guaranteed way to prevent one from forming. Managing conditions like diabetes and high blood pressure remains incredibly important for your long-term cardiovascular and metabolic wellbeing, and ensures you are healthy enough for any procedures you might need, even if it does not directly prevent a polyp from forming or returning [5].

Common questions in this guide

What causes uterine polyps?
There is no single proven cause, and doctors often cannot identify why an individual polyp formed. Polyps may arise from localized tissue growth, acquired changes in polyp cells, and the way the uterine lining responds to estrogen and progesterone.
Do obesity, diabetes, or high blood pressure cause uterine polyps?
Studies have found that obesity or higher body mass index and diabetes are associated with polyps in some groups, but they have not been proven to directly cause them. Evidence for hypertension is weaker, and having any of these conditions does not mean you caused the polyp.
Can tamoxifen or hormone therapy increase the chance of a uterine polyp?
Tamoxifen and certain hormone therapies are associated with a higher likelihood of polyps, but they are contributing factors rather than a universal cause. Do not stop or change prescribed treatment without speaking with the prescribing clinician.
Should a uterine polyp be removed after menopause?
The decision depends on bleeding, age and menopausal status, ultrasound appearance, polyp features, and medical history. Many polyps are benign, but postmenopausal bleeding should be evaluated promptly, and removal may be recommended so the tissue can be examined.
Can uterine polyps go away on their own?
In younger premenopausal people, some polyps regress on their own, while they are more likely to persist after menopause. Your clinician can recommend monitoring or removal based on your symptoms and individual risk factors.
How can doctors tell whether a uterine polyp is benign or cancerous?
If the polyp is removed, a pathology lab examines the tissue under a microscope. This can distinguish a benign polyp from hyperplasia with atypia or cancer.

Related questions

How Long to Avoid Sex After Hysteroscopic Polypectomy? Can a Uterine Polyp Cause Bleeding, Pain, or Discharge? Can a Small Endometrial Polyp Disappear Without Treatment? Can a Normal TV Ultrasound Miss an Endometrial Polyp? Can Tamoxifen or Hormone Therapy Cause Uterine Polyps?
Show more
When Is Bleeding From a Uterine Polyp an Emergency? Can a Uterine Polyp Cause Iron-Deficiency Anemia, Too? What Happens During an SIS Exam for a Uterine Polyp? Is Office Hysteroscopy Painful? Uterine Polyp Anesthesia Does a Thickened Endometrium Mean a Polyp on Ultrasound? Can a Normal Biopsy Miss a Uterine Polyp? Hysteroscopy Can a D&C Miss or Leave Behind an Endometrial Polyp? Can Uterine Polyps Be Prevented or Inherited? What to Know Does an Asymptomatic Uterine Polyp Need to Be Removed? How Common Are Uterine Polyps Before and After Menopause? Can a Pap Test Find an Endometrial or Uterine Polyp? Endometrial Polyp: Saline Ultrasound or Hysteroscopy? How Often Should an Asymptomatic Uterine Polyp Be Monitored? What Is the Difference Between Uterine Polyps and Fibroids?

Get notified when new evidence is published on uterine polyp.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (20)
  1. 1

    Abnormal expression of Hippo-YAP1 signalling pathway and progesterone resistance mechanism in endometrial polyps.

    Yu X, Kong W, Shang K, et al.

    Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 2025; (45(1)):2533965 doi:10.1080/01443615.2025.2533965.

    PMID: 40702758
  2. 2

    Association between redundant endometrium and endometrial polyps: a pilot study.

    Detti L, Peregrin-Alvarez I, Saed GM

    Minerva obstetrics and gynecology 2023; (75(3)):219-226 doi:10.23736/S2724-606X.21.04887-9.

    PMID: 34282611
  3. 3

    Immunohistochemical assessment of symptomatic postmenopausal endometrial polyps in tamoxifen users and nonusers: a case control study.

    Dibi RP, Zettler CG, Vanin CMM, et al.

    Sao Paulo medical journal = Revista paulista de medicina 2020; (138(1)):64-68 doi:10.1590/1516-3180.2018.0346.R4.19112019.

    PMID: 32215462
  4. 4

    Endometrial polyps are non-neoplastic but harbor epithelial mutations in endometrial cancer drivers at low allelic frequencies.

    Sahoo SS, Aguilar M, Xu Y, et al.

    Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2022; (35(11)):1702-1712 doi:10.1038/s41379-022-01124-5.

    PMID: 35798968
  5. 5

    Metabolic syndrome as a predictor of endometrial polyps in postmenopausal women.

    Bueloni-Dias FN, Spadoto-Dias D, Delmanto LR, et al.

    Menopause (New York, N.Y.) 2016; (23(7)):759-64 doi:10.1097/GME.0000000000000616.

    PMID: 27116465
  6. 6

    Survivin Expression in Simple Endometrial Polyps and Tamoxifen-associated Endometrial Polyps.

    Gokmen Karasu AF, Sonmez FC, Aydin S, et al.

    International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2018; (37(1)):27-31 doi:10.1097/PGP.0000000000000376.

    PMID: 28319569
  7. 7

    Association of ovarian hyperthecosis with endometrial polyp, endometrial hyperplasia, and endometrioid adenocarcinoma in postmenopausal women: a clinicopathological study of 238 cases.

    Zhang C, Sung CJ, Quddus MR, et al.

    Human pathology 2017; (59()):120-124 doi:10.1016/j.humpath.2016.09.021.

    PMID: 27746268
  8. 8

    Risk of Endometrial Polyps, Hyperplasia, Carcinoma, and Uterine Cancer After Tamoxifen Treatment in Premenopausal Women With Breast Cancer.

    Ryu KJ, Kim MS, Lee JY, et al.

    JAMA network open 2022; (5(11)):e2243951 doi:10.1001/jamanetworkopen.2022.43951.

    PMID: 36441547
  9. 9

    The association between endometrial polyps and metabolic syndrome: a case-control study.

    Özkan NT, Tokmak A, Güzel Aİ, et al.

    The Australian & New Zealand journal of obstetrics & gynaecology 2015; (55(3)):274-8 doi:10.1111/ajo.12339.

    PMID: 26044674
  10. 10

    Is there any relationship between benign endometrial pathologies and metabolic status?

    Kaya S, Kaya B, Keskin HL, et al.

    Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 2019; (39(2)):176-183 doi:10.1080/01443615.2018.1469606.

    PMID: 30286675
  11. 11

    Evaluation of Comt2, Comt3, Cyp1b1, and Esr1 gene polymorphisms as risk factor for endometrial polyp.

    Tcherniakovsky M, de Oliveira E, Martinelli Sonnenfeld M, et al.

    Women & health 2023; (63(10)):818-827 doi:10.1080/03630242.2023.2272206.

    PMID: 37908103
  12. 12

    Systemic hypertension and diabetes mellitus as predictors of malignancy among women with endometrial polyps: a meta-analysis of observational studies.

    Pergialiotis V, Prodromidou A, Siotos C, et al.

    Menopause (New York, N.Y.) 2016; (23(6)):691-7 doi:10.1097/GME.0000000000000602.

    PMID: 26953656
  13. 13

    The association between endometrial polyps and insulin resistance from the expression of PI3K and AKT proteins perspective.

    Li X, Wang F, Chen M, et al.

    BMC women's health 2024; (24(1)):366 doi:10.1186/s12905-024-03218-5.

    PMID: 38909214
  14. 14

    Comprehensive Analysis of Risk Factors for Recurrence in Women of Reproductive Age Undergoing Hysteroscopic Polypectomy.

    Fırtına Tuncer S, Sağnıç S, Tuncer HA

    Medical science monitor : international medical journal of experimental and clinical research 2025; (31()):e950098 doi:10.12659/MSM.950098.

    PMID: 41097829
  15. 15

    Endometrial Polyps.

    Han MN, Munro MG

    Obstetrics and gynecology 2026; (148(4)):489-507 doi:10.1097/AOG.0000000000006232.

    PMID: 41818771
  16. 16

    Prevalence of and risk factors for endometrial polyps among asymptomatic postmenopausal women with uterovaginal prolapse.

    Weigel GM, Baison GN, Mihalov L, Mupombwa T

    American journal of obstetrics and gynecology 2025; (232(2)):196.e1-196.e6 doi:10.1016/j.ajog.2024.08.001.

    PMID: 39127165
  17. 17

    Endometrial polyps: Is the prediction of spontaneous regression possible?

    Yuksel S, Tuna G, Celik HG, Salman S

    Obstetrics & gynecology science 2021; (64(1)):114-121 doi:10.5468/ogs.20242.

    PMID: 33321559
  18. 18

    Expectant management as a primary approach for asymptomatic endometrial polyps: An ambispective cohort study.

    Silva AR, Santos M, Coelho A, et al.

    European journal of obstetrics, gynecology, and reproductive biology 2026; (319()):114986 doi:10.1016/j.ejogrb.2026.114986.

    PMID: 41637906
  19. 19

    The risk of malignancy in uterine polyps: A systematic review and meta-analysis.

    Uglietti A, Buggio L, Farella M, et al.

    European journal of obstetrics, gynecology, and reproductive biology 2019; (237()):48-56 doi:10.1016/j.ejogrb.2019.04.009.

    PMID: 31009859
  20. 20

    Factors Associated with Malignancy in Hysteroscopically Resected Endometrial Polyps: A Systematic Review and Meta-Analysis.

    Sasaki LMP, Andrade KRC, Figueiredo ACMG, et al.

    Journal of minimally invasive gynecology 2018; (25(5)):777-785 doi:10.1016/j.jmig.2018.02.004.

    PMID: 29454147

This page is for informational purposes only and does not constitute medical advice about uterine polyps. Contact a healthcare professional promptly for bleeding after menopause, and ask your clinician how your medications and health conditions affect your care.